Matthew Clark

Dr. Matt Clark has over 23 years of research, development, and acquisition experience in neuroscience, pharmaceutical, vaccine, and drug-device combination product development as a soldier-scientist and leader across the US Government. Most recently he led White House International COVID Response Operations. Hand selected, he was responsible for senior policy advice and operations involving donating >1.2 billion COVID vaccines to >115 countries bilaterally, through COVAX involving Gavi, WHO, UNICEF & PAHO global organizations, and through the African Vaccine Acquisition Trust managed by the African Union. He coordinated operations with Countermeasures Acceleration Group (formerly Operation Warp Speed); Departments of State, HHS, and DOD; USAID; NIH; FDA; CDC; and FEMA. During his time on the team he was directly responsible for shipping over 534 million doses of COVID vaccine to mostly low and middle income countries while setting the conditions for the rest. Maximizing public-private partnerships, he worked the most challenging medical product development efforts facing our nation, including the COVID response.

Previously, Dr. Clark was the former Lead PM for the Vaccine Team of Operation Warp Speed (OWS), served as the Army Director for Medical Systems, and led the Chemical Defense Pharmaceuticals Joint Product Management Office in the Department of Defense (DOD). He commanded medical clinics overseas, directed a branch of a national lab focused on neurobehavioral toxicology and preclinical drug development, and led a cross-agency collaborative research facility. He served as the deputy commander and chief operating officer of the DOD’s organization that manages the advanced development of military medical products and served as the deputy director of the strategic planning and programming cell for an international $2+ billion medical research and materiel organization.

He has published on psychopharmacology, medical product development, leader development, support for military families, developmental language disorders, learning, and motivation. He has over 30 publications and professional reports, two books, and an Edison Award (Gold) for Innovation. He has been a featured panelist on medical product development in the DOD at the two recent BIO International Conventions.